This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 28, 2023.
Return to the list of Patented Medicine Litigation page.
Apixaban
ELIQUIS – Bristol-Myers Squibb Canada Co. (NOC Search)
Patents:
- 2461202: TEVA, JAMP, RIVA, SUN PHARMA, ACCORD HEALTHCARE, APOTEX, PHARMASCIENCE, , SANDOZ
- 2791171: JAMP, RIVA, TEVA, ACCORD HEALTHCARE, APOTEX, SUN PHARMA, PHARMASCIENCE, , SANDOZ
- 3620880: JAMP
Unknown/Other
ACCORD HEALTHCARE
APOTEX
- Appeal – A-178-19 (2019 FCA 194)
- Other – 19-A-17
- PM(NOC) – T-350-18 – T-351-18 (2019 FC 1379)
JAMP
PHARMASCIENCE
- Appeal – A-31-21 – A-32-21 (2022 FCA 142)
- PM(NOC) – T-97-19 (2023 FC 1023, 2021 FC 354) – T-98-19
RIVA
SANDOZ
SUN PHARMA
- PM(NOC) – T-373-21
TEVA
- PM(NOC) – T-1575-18
Return to the Patented Medicine Litigation page.